Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kanishka T Jayasundera

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Ophthalmic Genetics|March 17, 2022
Adherence and satisfaction in Argus II prosthesis users: a self determination theory modelMariam Khan, Kari Branham, Kanishka T Jayasundera, et al.
Retina (Philadelphia, Pa.)|December 9, 2025
Modelling Natural History and Cost-Effectiveness of Gene-Agnostic Treatment in Retinitis PigmentosaPatrick W Sullivan, Albert I Wertheimer, Sandeep Grover, et al.
Ophthalmic Genetics|February 27, 2020
Patient-reported outcome measures in inherited retinal degeneration gene therapy trialsGabrielle D Lacy, Maria Fernanda Abalem, David C Musch, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|January 8, 2024
Autoantibodies Against Bestrophin in Non-Paraneoplastic Acute Exudative Polymorphous Vitelliform MaculopathyWarren W Pan, Breanna M Tracey, Kanishka T Jayasundera, et al.
Ophthalmic Genetics|January 7, 2021
Clinical trial design for neuroprotection in <i>RHO</i> autosomal dominant retinitis pigmentosa; outcome measure considerationsBenjamin Otte, Chris Andrews, Gabrielle Lacy, et al.
American Journal of Ophthalmology|December 22, 2023
Functional Vision in Patients With Biallelic USH2A VariantsElise Heon, Michele Melia, Laura E Bocchino, et al.
The New England Journal of Medicine|May 6, 2024
Gene Editing for <i>CEP290</i>-Associated Retinal DegenerationEric A Pierce, Tomas S Aleman, Kanishka T Jayasundera, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Ophthalmic Genetics|March 17, 2022
Adherence and satisfaction in Argus II prosthesis users: a self determination theory modelMariam Khan, Kari Branham, Kanishka T Jayasundera, et al.
Retina (Philadelphia, Pa.)|December 9, 2025
Modelling Natural History and Cost-Effectiveness of Gene-Agnostic Treatment in Retinitis PigmentosaPatrick W Sullivan, Albert I Wertheimer, Sandeep Grover, et al.
Ophthalmic Genetics|February 27, 2020
Patient-reported outcome measures in inherited retinal degeneration gene therapy trialsGabrielle D Lacy, Maria Fernanda Abalem, David C Musch, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|January 8, 2024
Autoantibodies Against Bestrophin in Non-Paraneoplastic Acute Exudative Polymorphous Vitelliform MaculopathyWarren W Pan, Breanna M Tracey, Kanishka T Jayasundera, et al.
Ophthalmic Genetics|January 7, 2021
Clinical trial design for neuroprotection in <i>RHO</i> autosomal dominant retinitis pigmentosa; outcome measure considerationsBenjamin Otte, Chris Andrews, Gabrielle Lacy, et al.
American Journal of Ophthalmology|December 22, 2023
Functional Vision in Patients With Biallelic USH2A VariantsElise Heon, Michele Melia, Laura E Bocchino, et al.
The New England Journal of Medicine|May 6, 2024
Gene Editing for <i>CEP290</i>-Associated Retinal DegenerationEric A Pierce, Tomas S Aleman, Kanishka T Jayasundera, et al.
Pageof 1